Diphenyl diselenide reduces inflammation in the mouse model of pleurisy induced by carrageenan: Reduction of pro-inflammatory markers and reactive species levels

Inflammation Research

Volumn 61, Issue 10, 2012, Pages 1117-1124

  Luchese, Cristiane ^a   Prigol, Marina ^b   Duarte, Marta M M F ^b   Nogueira, Cristina W ^b  

^a CENTRO UNIVERSITÁRIO FRANCISCANO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Anti inflammatory; Cytokines; Diphenyl diselenide; Pleurisy; Reactive species; Selenium

Indexed keywords

CARRAGEENAN; CYTOKINE; DEXAMETHASONE; DIPHENYL DISELENIDE; EVANS BLUE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT ANIMAL; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MOUSE; NONHUMAN; PLEURA CAVITY; PLEURA FLUID; PLEURISY; STATISTICAL ANALYSIS; SWISS WEBSTER MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZENE DERIVATIVES; CARRAGEENAN; CYTOKINES; DISEASE MODELS, ANIMAL; LEUKOCYTE COUNT; MALE; MICE; ORGANOSELENIUM COMPOUNDS; PEROXIDASE; PLEURISY; REACTIVE OXYGEN SPECIES;

EID: 84866742887     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0504-0     Document Type: Article

References (45)

1. Lunardelli A, Leite CE, Pires MGS, Oliveira JR. Extract of the bristles of Dirphia sp. increases nitric oxide in a rat pleurisy model. Inflamm Res. 2006;55:129-35.
2. Lentsch AB, Ward PA. Regulation of experimental lung inflammation. Resp Physiol. 2001;128:17-21.
3. Saleh TSF, Calixto JB, Medeiros YS. Effects of antiinflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides. 1999;20:949-56.
4. Vinegar R, Truax JF, Selph JL, Voelker FA. Pathway of onset, development, and decay of carrageenan pleurisy in the rat. Fed Proc. 1982;41(9):2588-95.
5. Costa R, Fernandes ES, Menezes-de-Lima O, Campos MM, Calixto JB. Effect of novel selective non-peptide kinin B1 receptor antagonists on mouse pleurisy induced by carrageenan. Peptides. 2006;27:2967-75.
6. Froede TS, Buss ZS, dos Reis GO, Medeiros YS. Evidence of anti-inflammatory effects of Pioglitazone in the murine pleurisy model induced by carrageenan. Int Immunopharmacol. 2009;9:1394-400.
7. Nogueira CW, Zeni G, Rocha JBT. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev. 2004;104:6255-86.
8. Nogueira CW, Rocha JBT. Diphenyl diselenide a Janus-faced molecule. J Braz Chem Soc. 2010;21:2055-71.
9. Savegnago L, Trevisan M, Alves D, Rocha JBT, Nogueira CW, Zeni G. Antisecretory and antiulcer effects of diphenyl diselenide. Environ Toxicol Pharmacol. 2006;21:86-92.
10. Savegnago L, Pinto LG, Jesse CR, Rocha JBT, Nogueira CW, Zeni G. Spinal mechanisms of antinociceptive action caused by diphenyl diselenide. Brain Res. 2007;1162:32-7.
11. Rosa RM, Roesler R, Braga AL, Saffi J, Henriques JAP. Pharmacology and toxicology of diphenyl diselenide in several biological models. Braz J Med Biol Res. 2007;40:1287-304.
12. Luchese C, Nogueira CW. Diphenyl diselenide in its selenol form has dehydroascorbate reductase and glutathione S-transferaselike activity dependent on the glutathione content. J Pharm Pharmacol. 2010;62:1146-51.
13. Nogueira CW, Quinhones EB, Jung EAC, Zeni G, Rocha JBT. Anti-inflammatory and antinociceptive activity of diphenyl diselenide. Inflamm Res. 2003;52:56-63.
14. Savegnago L, Pinto LG, Jesse CR, Alves D, Rocha JBT, Nogueira CW, Zeni G. Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action. Eur J Pharmacol. 2007;555:129-38.
15. Prigol M, Schumacher RF, Nogueira CW, Zeni G. Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels. Toxicol Lett. 2009;189:35-9.
16. Maciel EN, Flores EMM, Rocha JBT, Folmer V. Comparative deposition of diphenyl diselenide in liver, kidney, and brain of mice. Bull Environ Contam Toxicol. 2003;70:470-6.
17. Savegnago L, Jesse CR, Santos ARS, Rocha JBT, Nogueira CW. Mechanisms involved in the antinociceptive effect caused by diphenyl diselenide in the formalin test. J Pharm Pharmacol. 2008;60:1679-86.
18. Paulmier C. Selenium reagents and intermediates. In: Organic Synthesis. Pergamon, Oxford; 1986.
19. Henriques MG, Rae GA, Cordeiro RS, Williams TJ. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse. Br J Pharmacol. 1992;106:579-82.
20. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132:345-52.
21. Loetchutinat C, Kothan S, Dechsupa S, Meesungnoen J, Jay-Gerin J, Mankhetkorn S. Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 20, 70-dichlorofluorescein diacetate assay. Radiat Phys Chem. 2005;72:323-31.
22. Vianna RMJ, Calixto JB. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Br J Pharmacol. 1998;123:281-91.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem. 1976;72:248-54.
24. Paul EL, Lunardelli A, Caberlon E, Oliveira CB, Santos RCV, Biolchi V, Bastos CMA, Moreira KB, Nunes FB, Gosmann G, Oliveira JR. Anti-inflammatory and immunomodulatory effects of Baccharis trimera aqueous extract on induced pleurisy in rats and lymphoproliferation in vitro. Inflammation. 2009;32:419-25.
25. Froede TS, Medeiros YS. Myeloperoxidase and adenosinedeaminase levels in the pleural fluid leakage induced by carraggenan in the mouse model of pleurisy. Med Inflamm. 2001;10:223-7.
26. Zhao L, Tao JY, Zhang SL, Pang R, Jin F, Dong JH, Guo YJ. Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb. Inflammation. 2007;30:213-23.
27. Cuzzocrea S, Mazzon E, Calabro G, Dugo L, Sarro A, Loo FAJV, Achille PC. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med. 2000;162:1859-66.
28. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214:149-60.
29. Oliveira SHP, Canetti C, Ribeiro RA, Cunha FQ. Neutrophil migration induced by IL-1b depends upon LTB4 released by macrophages and upon TNF-α and IL-1b released by mast cells. Inflammation. 2008;31:36-46.
30. Utsunomiya I, Nagai S, Oh-ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenan-induced pleurisy. J Immunol. 1991;147:1803-9.
31. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, Van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997;6:315-25.
32. Alonzi T, Fattori E, Cappelletti M, Ciliberto G, Poli V. Impaired stat3 activation following localized inflammatory stimulus in IL-6 deficient mice. Cytokine. 1998;10:13-8.
33. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:460-75.
34. Morioka N, Inoue A, Hanada T, Kumagai K, Takeda K, Ikoma K, Hide I, Tamura Y, Shiomi H, Dohi T, Nakata Y. Nitric oxide synergistically potentiates interleukin-1 beta-induced increase of cyclooxigenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: involvement of cGMP-independent mechanisms. Neuropharmacology. 2002;43:868-76.
35. O'Shaughnessy MC, Vetsika EK, Inglis JJ, Carleson J, Haigh R, Kidd BL, Winyard PG. The effect of substance P on nitric oxide release in a rheumatoid arthritis model. Inflamm Res. 2006;55:236-40.
36. Menegazzi M, Di Paola R, Mazzon E, Genovese T, Crisafulli C. Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol Res. 2008;58:22-31.
37. Hort MA, Straliotto MR, Netto PM, Rocha JBT, de Bem AF, Ribeiro-do-Valle RM. Diphenyl diselenide effectively reduces atherosclerotic lesions in LDLr-/-mice by attenuation of oxidative stress and inflammation. J Cardiovasc Pharmacol. 2011;58:91-101.
38. Meotti FC, Stangherlin EC, Zeni G, Nogueira CW, Rocha JBT. Protective role of aryl and alkyl diselenides on lipid peroxidation. Environ Res. 2004;94:276-82.
39. + ATPase and delta-aminolevulinic acid dehydratase in the rat brain. Neurochem Res. 2008;33:167-78.
40. de Bem AF, Protella RD, Farina M, Perottoni J, Paixao MW, Nogueira CW, Rocha JBT. Low toxicity of diphenyl diselenide in rabbits: a long-term study. Basic Clin Pharmacol Toxicol. 2007;101:47-55.
41. Prigol M, Bruning CA, Nogueira CW, Zeni G. The role of the glutathione system in seizures induced by diphenyl diselenide in rat pups. Chem Biol Interact. 2011;193:65-70.
42. Cuzzocrea S, Crisafulli C, Mazzon E, Esposito E, Muià C, Abdelrahman M, Di Paola R, Thiemermann C. Inhibition of glycogen synthase kinase-3 beta attenuates the development of carrageenan-induced lung injury in mice. Br J Pharmacol. 2006;149:687-702.
43. Chen CC, Chow MP, Huang WC, Lin YC, Chang YJ. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factorkappaB: structure-activity relationships. Mol Pharmacol. 2004;66:683-93.
44. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P, Morittu VM, Procopio A, Britti D, Cuzzocrea S. The effects of oleuropein aglycone, an olive oil compound, in a mouse model. Clin Nutr. 2011;30:533-40.
45. Shin KM, Shen L, Park SJ, Jeong JH, Lee KT. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NFkappaB inactivation. J Pharm Pharmacol. 2009;61(4):479-86.